Hypothesis

Senescent cells secrete a specific IL‑33 isoform (the truncated, secreted form) that acts as a negotiator by steering macrophages toward an anti‑inflammatory, pro‑repair phenotype; with aging or chronic stress the splicing shifts toward the full‑length, nuclear‑retained IL‑33 that amplifies fibroblast activation and fibrosis.

Mechanistic Rationale

IL‑33 undergoes alternative splicing yielding a secreted isoform (ssIL‑33) and a nuclear isoform (nsIL‑33). Senescent fibroblasts in acute wound environments show elevated SRSF3 activity, favoring ssIL‑33 release. This isoform binds ST2 on alternatively activated macrophages, increasing IL‑10 and TGF‑β1 release, which limits myofibroblast expansion and promotes matrix remodeling. In aged or persistently injured tissue, oxidative stress modifies SRSF3 phosphorylation, reducing ssIL‑33 production and increasing nsIL‑33 accumulation. Nuclear IL‑33 then acts as a transcriptional co‑activator for AP‑1 genes in fibroblasts, driving α‑SMA expression and collagen deposition. Thus the same senescent cell population can switch from negotiator to damage amplifier via an IL‑33 isoform toggle.

Experimental Plan

1. Identify isoform balance – Isolate p16+/p21+ senescent fibroblasts from young (3‑mo) and aged (24‑mo) mouse skin after excisional wound. Perform RT‑PCR with isoform‑specific primers and Western blot for ssIL‑33 vs nsIL‑33. Expect higher ssIL‑33/nsIL‑33 ratio in young wounds.
2. Loss‑of‑function – Use a p16‑CreER;Srsf3^fl/fl mouse to delete SRSF3 specifically in senescent cells. Assess wound closure, m

...

Hypothesis: Timed NAD+ supplementation disrupts the SASP‑CD38‑NAD+ sink and prevents resistance to intermittent senolytics

Core idea Intermittent dasatinib + quercetin (D+Q) clears senescent cells but triggers a compensatory SASP surge that up‑regulates CD38 in neighboring cells, draining NAD+ and blunting SIRT1 activity. This NAD+ depletion creates a microenvironment that protects residual senescent cells and drives resistance observed at week 4. Supplying an NAD+ precursor (e.g., nicotinamide riboside, NR) during the SASP peak window should replenish NAD+, sustain SIRT1‑mediated deacetylation of p53 and FOXO, and thereby enhance senolytic‑induced apoptosis while blocking the CD38‑driven sink.

Mechanistic rationale

1. SASP factors (IL‑6, IL‑8, MCP‑1) induce CD38 expression via STAT1/STAT2 signaling [4].
2. CD38 hydrolyzes NAD+ to ADP‑ribose, lowering intracellular NAD+ and reducing SIRT1 deacetylase activity [5].
3. Low NAD+ shifts the balance toward a pro‑survival senescent phenotype by decreasing p53 acetylation and increasing NF‑κB activity, which sustains SASP production.
4. Intermittent D+Q creates a pulsatile SASP peak (max at ~day 3 post‑dose) that coincides with the window when NAD+ levels are lowest; providing NR at this moment restores NAD+, reactivates SIRT1, and promotes senescent cell clearance.

Testable predictions

• In aged mice treated with intermittent D+Q alone, NAD+ in spleen and liver drops ~30 % at day 4 post‑dose and returns to baseline by day 7.

Hypothesis\nIntermittent fasting (IF) increases colonic tryptophan metabolism by Clostridium sporogenes through upregulation of the fldC gene, raising circulating indole‑3‑propionic acid (IPA). Elevated IPA activates the pregnane X receptor (PXR) in intestinal epithelial cells, which triggers a downstream signaling cascade that boosts hepatic fibroblast growth factor 21 (FGF21) secretion and enhances systemic SIRT1 activity. This IPA‑PXR‑FGF21‑SIRT1 axis improves NAD+ bioavailability and promotes favorable DNA methylation patterns, thereby decelerating epigenetic age as measured by GrimAge and PhenoAge clocks.\n\n## Mechanistic Rationale\n1. IF → ↑ C. sporogenes fldC expression → ↑ IPA (supported by [7]).\n2. IPA is a potent PXR agonist; PXR activation in gut epithelium drives expression of cytochrome P450 enzymes and transporters that alter bile acid pools and stimulate enteroendocrine L‑cells to release FGF21 (extrapolating from PXR‑FGF21 links in liver and intestine [5,6]).\n3. FGF21 acts on hypothalamus and adipose tissue to increase NAD+ biosynthesis via NAMPT upregulation and to activate SIRT1 deacetylase activity (known FGF21‑SIRT1 crosstalk [8]).\n4. Elevated SIRT1 deacetylates histone H3K9 and promotes DNMT1 inhibition, leading to a younger methylome (SIRT1‑DNA methylation relationship demonstrated in aging models).\n5. Consequently, individuals with higher fasting‑induced IPA show slower epigenetic aging.\n\n## Testable Predictions\n- In a human crossover trial, participants undergoing 16:8 IF for 4 weeks will exhibit a ≥2‑fold increase in plasma IPA re

Hypothesis

Age‑related NAD+ depletion in adrenal zona reticularis cells does not simply reflect passive damage; it actively reprograms steroidogenic capacity by suppressing SIRT1‑dependent deacetylation of FOXO1, thereby silencing DHEA‑synthetic enzymes while preserving cortisol‑producing pathways.

Mechanistic Basis

NAD+ is an essential cofactor for the sirtuin deacetylases, especially SIRT1, which regulates the transcriptional activity of FOXO1. In young adrenal cortex, NAD+-dependent SIRT1 keeps FOXO1 deacetylated, allowing FOXO1 to bind promoters of CYP17A1 and HSD3B2 and support DHEA synthesis. With aging, increased PARP‑mediated NAD+ consumption (driven by mitochondrial ROS and DNA damage) lowers NAD+ levels, reducing SIRT1 activity. Hyperacetylated FOXO1 exhibits reduced DNA binding and recruits histone deacetylases (HDACs) that promote a repressive chromatin state at DHEA‑specific genes. Importantly, the steroidogenic acute regulatory protein (StAR) and enzymes governing cortisol production (CYP11B1) are regulated primarily by cAMP‑PKA signaling and are less dependent on SIRT1‑FOXO1 dynamics, explaining why basal cortisol output is maintained while DHEA collapses.

This positions NAD+ decline as an upstream, programmable event that initiates a transcriptional retreat—consistent with the idea that the body "downgrades its metabolic ambitions" when long‑term investment in DHEA‑mediated functions (immune modulation, neuroprotection) becomes less advantageous.

Predictions & Experimental Design

1. **NAD+ repletion will fail to restore DHEA if SIRT1‑FOXO1 signal

Background

Anti-TIF1γ (anti-p155/140) antibodies in dermatomyositis (DM) carry the highest malignancy association among myositis-specific autoantibodies, with cancer prevalence reaching 40–80% in adults over 40. However, current surveillance relies on age-appropriate screening protocols that often detect malignancies only after significant tumor burden has accumulated. The NKG2D/MICA axis — a critical interface between innate immune surveillance and tumor immune evasion — remains unexplored as a predictive biomarker in this context.

Hypothesis

We hypothesize that in anti-TIF1γ-positive DM patients, tumor-derived soluble MICA (sMICA) shed via ADAM10/17 metalloproteinase activity progressively saturates the NKG2D receptor on circulating NK and CD8+ T cells, producing a quantifiable immunophenotypic signature — rising serum sMICA combined with declining NKG2D surface density — that predicts occult malignancy 8–18 months before detection by conventional imaging or biopsy.

Mechanistic Rationale

MICA is a stress-inducible NKG2D ligand upregulated on transformed cells. Tumors evade NK surveillance by shedding sMICA, which engages and downregulates NKG2D on effector cells. In DM, the concurrent autoimmune process generates baseline NKG2D activation via muscle-derived MICA expression, creating a dual-source signal. We propose that the transition from autoimmune-dominant (membrane-bound MICA on regenerating myofibers) to tumor-dominant (shed sMICA from occult neoplasm) sMICA kinetics produces a detectable inflection point characterized by:

1. **sMICA trajectory acceler

Hypothesis

Serum indole-3-propionic acid (IPA) modulates the rate of biological aging by altering DNA methylation patterns through activation of the pregnane X receptor (PXR) in intestinal epithelial and immune cells.

Rationale

• Existing data show IPA is produced exclusively by gut Clostridium species from tryptophan [1,3] and correlates strongly with the bacterial gene fldC (r=0.80) [1].
• IPA activates PXR, driving anti‑inflammatory, gut‑barrier and insulin‑sensitizing effects [1,3]
• PXR signaling regulates expression of DNA methyltransferases (DNMT1, DNMT3A) and demethylases (TET2) in hepatocytes and macrophages, a link demonstrated in xenobiotic metabolism studies [6]
• Therefore, fluctuations in intestinal IPA concentration could shift the DNMT/TET balance, producing measurable changes in epigenetic clocks such as GrimAge or PhenoAge.

Novel Mechanistic Insight

We propose that IPA‑bound PXR recruits co‑repressors that suppress DNMT transcription while enhancing TET activity, leading to locus‑specific hypomethylation at promoters of pro‑inflammatory genes (e.g., IL6, TNF). This epigenetic reprogramming would reduce inflammaging‑associated methylation signatures, thereby lowering biological age estimates.

Testable Predictions

1. **Cross‑se

Hypothesis

Age-related loss of bile salt hydrolase (BSH) activity depletes secondary bile acids such as deoxycholic acid (DCA), reducing FXR activation in liver and brain. This creates a self‑reinforcing loop of metabolic inflexibility and neuronal rigidity that manifests as cognitive aging. Restoring secondary bile acid signaling should re‑introduce controlled uncertainty, reset FXR‑dependent transcriptional dynamics, and improve cognitive flexibility.

Mechanistic Rationale

• Hepatic FXR downregulation with age and Western diet reduces mitochondrial oxidative phosphorylation and locks metabolic inflexibility [3].
• FXR deficiency accelerates age‑related liver pathology including NASH‑like damage and cholestasis [4].
• Secondary bile acids like DCA are potent FXR agonists; their age‑related depletion through reduced BSH activity likely drives transcriptional rigidity (via altered FXR‑dependent gene regulation) and epigenetic consolidation (5hmC marks that restrict dynamic responses) [1].
• Eight BSH phylotypes with distinct substrate specificity decline with age, and microbiota remodeling partially restores bile acid ratios and reduces inflammation [2].
• FXR influences neuron differentiation and cytoskeleton organization [3], linking hepatic metabolic state to neuronal plast

Hypothesis

The core clock repressor REV‑ERBα directly rhythms eosinophil IL‑4 production, creating a temporal window that synchronizes fibro‑adipogenic progenitor (FAP) activation with the regenerative phase of muscle injury. Loss of this circadian gating desynchronizes eosinophil‑FAP crosstalk, shifting repair toward fibrosis rather than regeneration.

Mechanistic Basis

Recent work shows that muscle stem cell clocks modulate NAD+ regeneration and PARP1 activity during repair [3]. Eosinophils support muscle repair by secreting IL‑4 to stimulate FAPs [5], and REV‑ERBα controls chemokine rhythms in myeloid cells [2]. We propose that REV‑ERBα binds to regulatory elements of the Il4 locus in eosinophils, repressing transcription during the active phase and permitting IL‑4 expression during the rest phase. This creates a circadian IL‑4 pulse that aligns with the peak of FAP responsiveness, which is itself driven by muscle‑stem‑cell‑derived NAD+ rhythms [3]. When REV‑ERBα is absent, IL‑4 becomes constitutively low or mistimed, uncoupling eosinophil help from FAP activation and promoting maladaptive fibroblast differentiation and collagen deposition.

Experimental Plan

1. Cell‑specific knockout – Generate eosinophil‑specific Rev‑erbα^fl/fl;Il5cre mice and controls.
2. In vivo muscle injury – Induce cardiotoxin injury in tibialis anterior; harvest tissue at 4‑h intervals o

Hypothesis

During cyclic OSKM‑induced partial reprogramming, autophagy does not merely remove damaged mitochondria first; it executes a tightly ordered substrate hierarchy—mitophagy → ER‑phagy → aggrephagy → ribophagy—that gates the epigenetic reset. Disrupting the sequence, for example by delaying ER‑phagy while keeping mitophagy intact, will uncouple mitochondrial ROS reduction from chromatin remodeling and produce incomplete reprogramming despite normal autophagy flux.

Rationale

Recent work shows a transient autophagy peak early in reprogramming that depends on Sox2‑mediated mTOR suppression and is required for efficiency1. Mitophagy reduces ROS2 and continuous autophagy blocks iPSC formation, indicating a need for precise timing1. Outside reprogramming, stress‑induced muscle atrophy shifts autophagic selectivity toward ER‑phagy, with OPTN and SEC62 up‑regulated early4, proving cells can re‑prioritize cargos. Yet no study has tracked the full order of organelle clearance during cyclic OSKM pulses or linked receptor dynamics to demethylation waves that occur mainly during recovery phases3.

We propose that the hierarchy functions as a molecular checkpoint: mitochondria are cleared first to lower ROS,

Hypothesis

Telomere shortening raises the informational entropy of the genome, which propagates to the endoplasmic reticulum and shifts the BCL-2/Beclin-1 equilibrium toward inhibition, thereby dampening autophagy and accelerating age-related decline.

Mechanistic link

Critically short telomeres lose shelterin protection, activating a persistent DNA-damage response that remodels local chromatin into a higher-entropy state. This altered chromatin state influences the transcription of microRNAs such as miR-30a and miR-181a, which directly target BCL-2 or Beclin-1 mRNAs, biasing the balance toward the inhibitory complex. It's also true that telomere-associated changes in nuclear lamina tension modify ER-mitochondria contact sites, reducing calcium flux that normally activates AMPK-dependent phosphorylation of BCL-2 (Ser70) and Beclin-1 (Thr119). Less phosphorylation stabilizes the BCL-2/Beclin-1 interaction at the ER, suppressing Vps34/Vps15 recruitment and autophagosome nucleation.

Predictions

1. Fibroblasts with telomerase-induced telomere elongation will display reduced BCL-2/Beclin-1 co-immunoprecipitation and increased LC3-II turnover, even when p53 is knocked down.
2. Acute telomere uncapping by inducible TRF2 shortening (without altering overall length) will raise the BCL-2/Beclin-1 interaction within 6 h, preceding detectable changes in global transcription.
3. Treatment with a histone-deacetylase inhibitor (e.g., SAHA) that lowers chromatin entropy will mimic telomere lengthening by decreasing the inhibitory complex and restoring autophagy in senescent ce

Hypothesis

The rate of mitochondrial DNA polymerase γ (Pol γ)–mediated replication errors sets the pace of organismal aging by altering mitochondrial metabolite fluxes that rewire nuclear epigenetic landscapes, rather than by causing wholesale bioenergetic failure.

Mechanistic Basis

Pol γ lacks proofreading activity in many tissues, leading to a bias toward G→A and T→C transitions on the light strand [1]. These mutations accumulate at regulatory regions such as the origin of light‑strand replication, where even low heteroplasmy disrupts glucose metabolism [2]. We propose that the primary consequence is not oxidative damage but a shift in the balance of TCA‑cycle intermediates—particularly an increase in succinate and a decrease in NAD⁺—that is exported to the cytosol. Elevated succinate inhibits α‑ketoglutarate‑dependent dioxygenases, causing histone and DNA hypermethylation, while reduced NAD⁺ diminishes sirtuin activity, together tightening chromatin and suppressing stress‑response genes. This retrograde signaling creates a feed‑forward loop: nuclear epigenetic changes further down‑regulate Pol γ subunits, increasing error rates.

Testable Predictions

1. Enhancing Pol γ fidelity (e.g., by overexpressing its exonuclease domain or administering a small‑molecule stabilizer) will lower heteroplasmy at the origin of light‑strand replication without changing overall ROS levels.
2. Animals with higher Pol γ fidelity will show younger epigenetic clocks (DNA methylation age) and

Hypothesis

Chronic non‑steroidal anti‑inflammatory drug (NSAID) use exacerbates age‑related increases in ileal ASBT expression, leading to exaggerated conjugated primary bile acid (CPBA) accumulation in serum and brain, which accelerates neuroinflammation and cognitive decline.

Mechanistic Rationale

1. Aging elevates intestinal ASBT – In aged rodents, glucocorticoid receptor (GR)‑mediated transactivation boosts ASBT expression and protein levels, driving heightened CPBA uptake despite reduced hepatic CYP7A1 activity [1](2).
2. NSAIDs compromise the intestinal barrier – Chronic NSAID ingestion increases epithelial permeability, facilitating bacterial translocation and endotoxin (LPS) influx, which triggers hepatic inflammation and a systemic rise in glucocorticoids.
3. Feed‑forward loop – Elevated glucocorticoids further activate intestinal GR, amplifying ASBT expression beyond age‑related baseline. More CPBA is absorbed, raising circulating and brain CPBA levels (especially taurocholic acid) [1].
4. Bile acid‑driven neurotoxicity – Brain CPBA accumulation disrupts microglial homeostasis, promotes oxidative stress, and exacerbates tau pathology, while altered FXR/TGR5 signaling skews immune responses toward a pro‑inflammatory state.
5. Outcome – The combined effect of age‑driven ASBT upregulation and NSAID‑induced barrier leak creates a vicious cycle that accelerates cognitive decline bey

Hypothesis

Senescent hypothalamic glial cells export miR‑146a‑loaded exosomes that directly suppress IκBα expression in neighboring GnRH neurons, thereby amplifying NF‑κB‑mediated repression of GnRH transcription beyond the cytokine‑driven IKKβ route.

Mechanistic rationale

• It's known that senescent astrocytes, microglia and tanycytes increase secretion of exosomes carrying miR‑146a, a small RNA best known for dampening TLR‑NF‑κB signaling in immune cells.
• We don't yet know if neuronal miR‑146a acts differently, but in GnRH neurons the induced silencing complex preferentially targets the 3′‑UTR of NFKBIA (IκBα) mRNA, reducing IκBα protein synthesis.
• Lower IκBα leaves p65/p50 free to translocate, sustaining NF‑κB activity even when cytokine levels fall.
• NF‑κB in turn drives transcription of miR‑146a in the senescent glial cells, creating a positive feedback loop that locks the neuroendocrine axis in a suppressed state.

This mechanism adds a post‑transcriptional layer to the IKKβ/IκBα/NF‑κB circuit described in 1 and 2, and explains why simply neutralizing SASP cytokines often fails to restore GnRH output in aged animals.

Testable predictions

1. Exosomal cargo – Exosomes isolated from cultured senescent hypothalamic glia will show ≥3‑fold enrichment of miR‑146a relative to exosomes from young glia (small‑RNA seq).

Hypothesis

Senescent memory B cells function as a rheostat that tempers germinal center reactions by secreting a senescence‑associated secretory phenotype (SASP) rich in TGF‑β1 and IL‑10, which epigenetically suppresses activation‑induced cytidine deaminase (AID) in neighboring naïve and centroblast B cells. This restraint limits off‑target somatic hypermutation (SHM) and curtails the emergence of autoreactive clones, thereby preserving peripheral B‑cell homeostasis at the cost of reduced antibody diversity—a trade‑off that becomes maladaptive with age as senescent B‑cell accumulation overly dampens AID activity.

Mechanistic rationale

• Aged B cells exhibit senescence markers (p16^INK4a^, p21^Cip1^) and a proinflammatory SASP [4]. Recent work shows that young senescent fibroblasts enrich for developmental and regenerative programs, suggesting SASP can be context‑dependent [7].
• TGF‑β1 and IL‑10 are known to induce DNA methylation of the Aicda promoter and to decrease AID transcription in B cells (https://doi.org/10.1016/j.immuni.2020.05.015).
• Homeostatic proliferation of long‑lived memory B cells suppresses lymphopoiesis, reversible upon depletion [6]; this effect may be mediated by SASP‑driven inhibition of AID‑dependent proliferation rather than mere niche competition.
• Reduced SHM quality in aged individuals, especially replacement mutations in Vκ4 CDRs/FRs, correlates with lower IL‑7, E2A, RAG, and lambda‑5 expression [1][2] and shows sex‑biased decline in Phase II SHM [3]; we propose that part of this deficit stems from extrinsic SASP‑mediated AID suppress

Hypothesis

Specific gut‑derived metabolites—particularly butyrate and indole‑3‑propionic acid—alter the biophysical environment of the neuronal proteostasis network, promoting the formation of thermodynamically stable, ordered amyloid‑like fibrils rather than disordered, amorphous aggregates. This structural shift reduces proteotoxic stress and rescues cognitive function independent of total aggregate load.

Mechanistic Rationale

1. Metabolite‑dependent proteostasis tuning – Butyrate inhibits histone deacetylases, increasing expression of heat‑shock proteins (Hsp70, Hsp90) that favor ordered fibril elongation [4]. Indole‑3‑propionic acid acts as an antioxidant, lowering oxidative modifications that promote amorphous aggregation [3].
2. Lysosomal pH modulation – SCFAs raise lysosomal luminal pH, enhancing cathepsin activity and facilitating the clearance of misfolded monomers before they nucleate toxic species [1].
3. Tryptophan‑kynurenine balance – Strains that limit IDO1 activity raise tryptophan availability for serotonin synthesis, which stabilizes synaptic vesicles and reduces stress‑induced misfolding [2]. Together, these actions bias the aggregation pathway toward a structured fibrillar state that is less disruptive to membranes and synapses.

Experimental Design

• Model: Germ‑free mice colonized with defined bacterial consortia: (i) a butyrate‑producing Clostridium cluster XIVa strain, (ii) an indole‑3‑propionic acid‑producing Bacteroides strain, (iii) a control consortium lacking these metabolites.
• Intervention: 8‑week colonization

Hypothesis

Age‑associated NAD+ decline reduces ATP‑dependent CK2 activity, which preferentially hinders the nuclear import of ERK1 relative to ERK2 because ERK1’s slower intrinsic shuttling kinetics make it more dependent on efficient NLS phosphorylation. This creates an ERK1‑cytoplasmic/ERK2‑nuclear signaling imbalance that promotes a senescent transcriptional program.

Mechanistic Basis

• ERK1/2 nuclear entry requires dual phosphorylation and importin7‑mediated transport, a process driven by CK2 phosphorylation of the Ser‑244/Pro‑245/Ser‑246 nuclear translocation sequence[1]
• ERK1 contains a 20‑aa insert N‑terminal to the poly‑alanine region that slows its nuclear accumulation compared with ERK2[2]
• CK2 is an ATP‑dependent kinase; its activity falls when cellular ATP declines[1]
• NAD+ depletion during aging elevates CD38 and PARP1 activity, consuming NAD+ and indirectly limiting ATP production via impaired oxidative phosphorylation[5]
• Low ATP therefore reduces CK2‑mediated NLS phosphorylation, disproportionately affecting the slower‑importing ERK1 isoform
• Persistent cytoplasmic ERK1 sustains MAPK feedback loops where oxidative stress inhibits phosphatases, maintaining ERK signaling[3]
• Simultaneously, NAD+ scarcity curtails the energetically

Hypothesis

Pre‑transplant mitochondrial priming with MitoQ and BDNF significantly improves engraftment survival, axonal outgrowth, and behavioral recovery of iPSC‑derived dopaminergic neural progenitors in rodent models of Parkinson’s disease.

Rationale

Recent iPSC‑based PD trials show safe transplantation but limited long‑term efficacy, it's largely due to poor cell survival and incomplete integration[1]. While dopaminergic progenitors acquire neurotransmitter phenotype, they often arrive at the graft site with compromised mitochondrial health, rendering them vulnerable to oxidative stress and inflammatory cues[3].

Exosome‑mediated mitochondrial transfer has been demonstrated to rescue bioenergetic deficits in stressed neurons[4]. Moreover, BDNF signaling activates PI3K/Akt pathways that promote mitochondrial biogenesis and attenuate apoptosis[5]—though we note that direct BDNF exposure can cause receptor desensitization if prolonged.

We're proposing that a brief (2‑hour) pre‑treatment of iPSC‑derived dopaminergic progenitors with MitoQ (a mitochondria‑targeted antioxidant) combined with a low‑dose BDNF pulse will:

• Boost mitochondrial membrane potential and ATP production.
• Reduce ROS‑induced DNA damage.
• Enhance TrkB‑mediated survival signaling without triggering receptor downregulation.

Testable Predict

Hypothesis

Berberine, via AMPK activation and PCSK9 inhibition, modulates the brain’s energy‑sensing machinery to convert age‑related neuronal loss from a passive degenerative process into an active, metabolically driven eviction of inefficient neurons.

Mechanistic Rationale

• AMPK activation signals low cellular ATP, a cue that in developing tissue triggers complement‑mediated synapse pruning and microglial phagocytosis ([1][2]).
• In aging neurons, sustained AMPK activation could raise the threshold for metabolic competence, marking cells with low oxidative phosphorylation or high ROS as targets for removal.
• Berberine’s inhibition of PCSK9 raises hepatic LDL‑R activity, lowering circulating LDL and potentially reducing lipid‑laden microglia that otherwise impair phagocytic capacity ([3][4]).
• Combined, these actions may shift the balance toward selective removal of high‑energy‑cost, low‑output neurons, thereby increasing ATP yield per surviving cell.

Testable Predictions

1. Marker shift – Chronic low‑dose berberine in 20‑month‑old mice will decrease neuronal death markers unrelated to activity (e.g., cleaved caspase‑3 in densely connected hippocampal CA1) while increasing markers of microglial phagocytosis (Iba1⁺/CD68⁺ contacts with NeuN⁺ cells lacking synaptic vesicle protein SV2A).
2. Metabolic read‑out – Isolated neurons from berberine‑treated aged brains will show higher ATP/ADP ratios and lower lactate production compared with vehicle controls, indicating improved metabolic efficiency per cell.
3. Network efficiency – In vivo two‑photon ca